Annovis Bio Inc ANVS
NYSE · United States · Health Technology
$1.19-0.08 (-6.69%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-14 | -0.40 | -0.45 | +11.8% | $0 | — | -2.8%$1.79→$1.74 |
| Q1 2026 | 2026-05-15 | -0.63 | -0.35 | -80.0% | — | — | -3.8%$2.13→$2.05 |
| Q4 2025 | 2026-03-13 | -0.39 | -0.30 | -30.0% | — | — | +15.0%$2.46→$2.83 |
| Q3 2025 | 2025-11-12 | -0.37 | -0.37 | 0.0% | — | — | +8.5%$2.11→$2.29 |
| Q2 2025 | 2025-08-12 | -0.32 | -0.39 | +17.9% | — | — | — |
| Q1 2025 | 2025-05-13 | -0.32 | -0.29 | -10.3% | — | — | — |
| Q4 2024 | 2025-03-21 | -0.43 | -0.20 | -115.0% | — | — | — |
| Q3 2024 | 2024-11-08 | -0.97 | -0.60 | -61.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.